2025-10-01 - Analysis Report
Okay, here's an analysis of UnitedHealth Group (UNH) based on the provided data, presented in a clear and concise format.

## UnitedHealth Group Inc (UNH) Stock Analysis

**Company Overview:** UnitedHealth Group Inc. is a diversified health care company providing a wide range of products and services.

### 1. Performance vs. S&P 500 (VOO)

*   **UNH Cumulative Return:** -19.29%
*   **VOO Cumulative Return:** 97.56%
*   **Absolute Divergence (Last Day):** -85.0

    *   **Analysis:** UNH has significantly underperformed the S&P 500. The cumulative return difference is substantial.

*   **Relative Divergence:** 9.9

    *   **Analysis:** The relative divergence of 9.9 indicates that the UNH's performance relative to the S&P 500 is near the lower end of its historical range.  This suggests significant underperformance compared to its past behavior.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha  | Beta | Cap(B) |
| ---------- | ------ | ------ | ------ | ---- | ------ |
| 2015-2017  | 58.0%  | 66.4%  | 30.0%  | 0.1  | 199.7  |
| 2016-2018  | 41.0%  | 70.4%  | 26.0%  | 0.1  | 225.7  |
| 2017-2019  | 36.0%  | 73.8%  | 14.0%  | 0.2  | 266.3  |
| 2018-2020  | -43.0% | 81.2%  | -67.0% | 0.5  | 317.7  |
| 2019-2021  | 16.0%  | 81.2%  | -30.0% | 1.5  | 454.9  |
| 2020-2022  | -1.0%  | 81.2%  | 0.0%   | 1.5  | 480.3  |
| 2021-2023  | 24.0%  | 80.8%  | 23.0%  | 0.4  | 476.9  |
| 2022-2024  | -27.0% | 78.8%  | -47.0% | 0.3  | 458.2  |
| 2023-2025  | -62.0% | 78.8%  | -124.0% | 1.3  | 313.5  |

*   **CAGR:** The CAGR has fluctuated significantly over the years, showing a declining trend recently.
*   **MDD:** The Maximum Drawdown (MDD) is consistently high, indicating significant volatility.
*   **Alpha:** Alpha has been negative in recent periods, implying underperformance relative to the market.
*   **Beta:** Beta values fluctuate, suggesting that UNH's volatility relative to the market has varied over time. Recent beta values are higher, indicating increased market sensitivity.
*   **Cap:** The market capitalization has generally increased over time, but has decreased recently.

### 2. Recent Price Action

*   **Current Price:** 346.115
*   **Last Market Data:** Price: 345.82, Previous Close: 345.18, Change: 0.19
*   **5-Day Moving Average:** 347.443
*   **20-Day Moving Average:** 336.9638
*   **60-Day Moving Average:** 301.1321

    *   **Analysis:** The current price is slightly below the 5-day moving average but above the 20-day and 60-day moving averages. This suggests a possible short-term downward trend, but still supported by longer term trend. The slight change in price relative to the previous close indicates minimal recent price movement.

### 3. Technical Indicators & Expectations

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 48.42 (Neutral)
*   **PPO:** -0.4568 (Neutral)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (1 shares - Very Safe - MRI:0.90)
*   **Recent (20-day) Relative Divergence Change:** 1.5 (+) - Short-term increase

    *   **Analysis:**  The MRI suggests a high investment recommendation. RSI is neutral. The PPO is also neutral. The hybrid signal suggests buying with available cash, based on the MRI score. The increase in the 20-day relative divergence suggests a short-term upward trend.
*   **Expected Return:** -23.0% (Long-term underperformance vs. S&P 500)

    *   **Analysis:** The expected return is negative, indicating that, based on current data, the model predicts UNH will underperform the S&P 500 over the next two years with a long-term investment strategy.

### 4. Recent News & Significant Events

*   **Mixed Sentiment:** The news headlines present a mixed picture.
    *   Some articles suggest a buying opportunity ("Should You Buy UnitedHealth Group (UNH) Stock Before October 28?") and potential turnaround ("1 Reason This Healthcare Stock's Turnaround Is on the Horizon").
    *   UBS sees upside potential ("UBS Sees Upside for UnitedHealth (UNH) Amid Medicare Advantage Restructuring").
    *   Other articles mention UnitedHealth in the context of broader market trends ("Beat the Market the Zacks Way: Helios Technologies, InterDigital, UnitedHealth in Focus").

### 4-2. Analyst Opinions

*   **Consensus:** Buy (Mean: 1.96)
*   **Target Price:** Average: 342.58, High: 626.00, Low: 198.00

    *   **Analysis:** Analyst consensus is generally positive, with a "Buy" rating. However, the wide range in target prices indicates uncertainty about the stock's future performance.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출       |
| ---------- | ---- | ---------- |
| 2025-08-11 | 3.76 | 111.62 B$  |
| 2025-05-07 | 6.9  | 109.58 B$  |
| 2024-11-04 | 6.56 | 100.82 B$  |
| 2024-08-09 | 4.58 | 98.86 B$   |
| 2025-08-11 | 4.58 | 98.86 B$   |

*   **Analysis:** Revenue has generally been increasing. EPS has fluctuated, with recent values lower than previous periods.

### 6. Financial Information (Quarterly)

**Revenue and Profitability:**

| Quarter      | Revenue      | Profit Margin |
| ------------ | ------------ | --------------- |
| 2025-06-30   | $111.62B    | 17.93%          |
| 2025-03-31   | $109.58B    | 21.70%          |
| 2024-12-31   | $100.81B    | 21.14%          |
| 2024-09-30   | $100.82B    | 22.84%          |
| 2024-06-30   | $98.86B     | 22.31%          |

**Capital and Profitability:**

| Quarter      | Equity      | ROE   |
| ------------ | ----------- | ----- |
| 2025-06-30   | $94.72B     | 3.60% |
| 2025-03-31   | $95.04B     | 6.62% |
| 2024-12-31   | $92.66B     | 5.98% |
| 2024-09-30   | $94.53B     | 6.41% |
| 2024-06-30   | $89.36B     | 4.72% |

*   **Analysis:** Revenue has been growing, but the profit margin has decreased in the most recent quarter. Equity has remained relatively stable. ROE has also decreased recently.

### 7. Overall Assessment

*   **Negative Performance:** UNH has significantly underperformed the S&P 500.
*   **Mixed Indicators:** Technical indicators and analyst opinions present a mixed outlook. The MRI is positive, but the expected return is negative. Analyst consensus is "Buy," but target prices vary widely.
*   **Financial Concerns:** While revenue is growing, profit margins and ROE have decreased recently, which is a cause for concern.
*   **News Sentiment:** Recent news is mixed, suggesting both potential opportunities and ongoing challenges.

**Conclusion:**

Based on this analysis, UNH appears to be facing some challenges. While analyst opinions and the MRI suggest potential upside, the stock's underperformance, declining profitability, and negative expected return warrant caution. Investors should carefully weigh the potential risks and rewards before making any investment decisions. Further research into the specific reasons for the underperformance and declining profitability is recommended.
